Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited

4502

Peringkat dalam Saham #375
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Harga Saham
$40.45
Kapitalisasi Pasar
$64.36B
Perubahan (1 hari)
1.19%
Perubahan (1 tahun)
43.11%
Negara
JP
Perdagangan Takeda Pharmaceutical Company Limited (4502)

Kategori

Healthcare
Riwayat pemecahan saham untuk Takeda Pharmaceutical Company Limited (4502)
Saham Takeda Pharmaceutical Company Limited (simbol: 4502) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Oct 22, 2026.
Satu lembar saham 4502 yang dibeli sebelum Oct 22, 2026 sekarang setara dengan 0 lembar saham 4502.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing